$TNXP
Tonix Pharmaceuticals Holding Corp.

2013 Q3 Form 10-Q Financial Statement

#000114420413046004 Filed on August 14, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2013 Q2 2012 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.450M $1.140M $1.020M
YoY Change 34.26% 11.76% 251.72%
% of Gross Profit
Research & Development $1.637M $944.0K $827.8K
YoY Change 148.03% 14.04% 1279.65%
% of Gross Profit
Depreciation & Amortization $0.00 $10.00K $10.00K
YoY Change 0.0%
% of Gross Profit
Operating Expenses $3.092M $2.086M $1.851M
YoY Change 78.73% 12.7% 414.15%
Operating Profit -$3.092M -$2.086M -$1.851M
YoY Change 12.7%
Interest Expense $0.00 $0.00 -$1.220M
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$3.090M -$2.090M -$3.070M
YoY Change 78.61% -31.92% 752.78%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.090M -$2.086M -$3.074M
YoY Change 78.61% -32.13% 753.8%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$873.5M -$954.0M -$1.793B
COMMON SHARES
Basic Shares Outstanding 4.877M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q3 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.400M $100.0K $1.300M
YoY Change -92.31%
Cash & Equivalents $7.400M $100.0K $1.300M
Short-Term Investments
Other Short-Term Assets $0.00 $0.00 $100.0K
YoY Change -100.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $7.500M $114.4K $1.400M
YoY Change 7400.0% -91.83%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $38.81K $100.0K
YoY Change -100.0% -61.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $100.0K $200.0K $100.0K
YoY Change 0.0% 100.0%
Total Long-Term Assets $100.0K $200.0K $100.0K
YoY Change 0.0% 100.04%
TOTAL ASSETS
Total Short-Term Assets $7.500M $114.4K $1.400M
Total Long-Term Assets $100.0K $200.0K $100.0K
Total Assets $7.600M $314.4K $1.500M
YoY Change 3700.0% -79.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.000M $1.461M $500.0K
YoY Change 42.86% 192.25%
Accrued Expenses $900.0K $601.6K $300.0K
YoY Change 800.0% 100.53%
Deferred Revenue
YoY Change
Short-Term Debt $300.0K $200.0K $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $2.100M $2.263M $800.0K
YoY Change 162.5% 182.85%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.100M $2.263M $800.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.100M $2.278M $800.0K
YoY Change 133.33% 184.75%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $17.97M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.400M -$1.964M $700.0K
YoY Change
Total Liabilities & Shareholders Equity $7.600M $314.4K $1.500M
YoY Change 3700.0% -79.04%

Cashflow Statement

Concept 2013 Q3 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income -$3.090M -$2.086M -$3.074M
YoY Change 78.61% -32.13% 753.8%
Depreciation, Depletion And Amortization $0.00 $10.00K $10.00K
YoY Change 0.0%
Cash From Operating Activities -$2.870M -$760.0K -$1.130M
YoY Change 120.77% -32.74% 391.3%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K $0.00 -$30.00K
YoY Change 0.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$10.00K $0.00 -$30.00K
YoY Change 0.0% -100.0% 200.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.22M 410.0K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -2.870M -760.0K -1.130M
Cash From Investing Activities -10.00K 0.000 -30.00K
Cash From Financing Activities 10.22M 410.0K 0.000
Net Change In Cash 7.340M -350.0K -1.160M
YoY Change -660.31% -69.83% -3966.67%
FREE CASH FLOW
Cash From Operating Activities -$2.870M -$760.0K -$1.130M
Capital Expenditures -$10.00K $0.00 -$30.00K
Free Cash Flow -$2.860M -$760.0K -$1.100M
YoY Change 121.71% -30.91% 378.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4877490 shares
dei Entity Registrant Name
EntityRegistrantName
Tonix Pharmaceuticals Holding Corp.
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2159156 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2197490 shares
CY2012Q4 us-gaap Cash
Cash
1785390 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
224659 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
114399 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38814 USD
CY2013Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
60312 USD
CY2013Q2 us-gaap Assets
Assets
314441 USD
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1461238 USD
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
601588 USD
CY2013Q2 us-gaap Interest Payable Current
InterestPayableCurrent
200000 USD
CY2012Q4 us-gaap Interest Payable Current
InterestPayableCurrent
0 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2262826 USD
CY2013Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
15137 USD
CY2013Q2 us-gaap Liabilities
Liabilities
2277963 USD
dei Trading Symbol
TradingSymbol
TNXP
dei Entity Central Index Key
EntityCentralIndexKey
0001430306
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
827788 USD
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 USD
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 USD
CY2013Q2 us-gaap Other Income
OtherIncome
0 USD
CY2012Q2 us-gaap Other Income
OtherIncome
0 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-16955525 USD
CY2012Q2 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 USD
CY2013Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
62565 USD
CY2012Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
6809 USD
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2197490 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2159156 shares
CY2013Q2 us-gaap Cash
Cash
68037 USD
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
46362 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
2010049 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46894 USD
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
60267 USD
CY2012Q4 us-gaap Assets
Assets
2117210 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
825837 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
309800 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1138792 USD
CY2012Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
19710 USD
CY2012Q4 us-gaap Liabilities
Liabilities
1158502 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
2159 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
16800829 USD
CY2012Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
15844280 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
958708 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
943995 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1684624 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1225416 USD
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1023150 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2402290 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
2085689 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
1850938 USD
us-gaap Operating Expenses
OperatingExpenses
3011303 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2085689 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1850938 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4086914 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3011303 USD
CY2013Q2 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 USD
us-gaap Other Income
OtherIncome
0 USD
us-gaap Other Income
OtherIncome
0 USD
CY2013Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
CY2012Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1224049 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1177026 USD
CY2013Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
28 USD
CY2012Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1297 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
50 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-900349 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-2085661 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-3073690 USD
us-gaap Net Income Loss
NetIncomeLoss
-4086864 USD
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.95
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.79
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.88
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2186537 shares
CY2012Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1713922 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2172921 shares
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
2197 USD
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
17965425 USD
CY2013Q2 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
19931144 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
-1963522 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
314441 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2117210 USD
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3155 USD
CY2013Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
100916 USD
CY2012Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6219886 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1141694 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1785887 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10735639 USD
us-gaap Operating Expenses
OperatingExpenses
4086914 USD
us-gaap Operating Expenses
OperatingExpenses
16955525 USD
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
7908 USD
us-gaap Other Income
OtherIncome
1875 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1177026 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1808376 USD
us-gaap Net Income Loss
NetIncomeLoss
-5088678 USD
us-gaap Net Income Loss
NetIncomeLoss
-19931144 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.09
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1648223 shares
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
833895 USD
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
24073 USD
tnxp Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
306666 USD
us-gaap Debt Issuance Costs
DebtIssuanceCosts
24000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
374870 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
374870 USD
us-gaap Depreciation
Depreciation
8080 USD
us-gaap Depreciation
Depreciation
6116 USD
us-gaap Depreciation
Depreciation
39721 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
196166 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
249543 USD
tnxp Beneficial Conversion Feature In Connection With Convertible Debentures
BeneficialConversionFeatureInConnectionWithConvertibleDebentures
0 USD
tnxp Beneficial Conversion Feature In Connection With Convertible Debentures
BeneficialConversionFeatureInConnectionWithConvertibleDebentures
426152 USD
tnxp Beneficial Conversion Feature In Connection With Convertible Debentures
BeneficialConversionFeatureInConnectionWithConvertibleDebentures
710000 USD
tnxp Common Stock Issued In Connection With Convertible Debentures
CommonStockIssuedInConnectionWithConvertibleDebentures
0 USD
tnxp Common Stock Issued In Connection With Convertible Debentures
CommonStockIssuedInConnectionWithConvertibleDebentures
81337 USD
tnxp Common Stock Issued In Connection With Convertible Debentures
CommonStockIssuedInConnectionWithConvertibleDebentures
426152 USD
tnxp Warrants Issued In Connection With Convertible Debentures
WarrantsIssuedInConnectionWithConvertibleDebentures
0 USD
tnxp Warrants Issued In Connection With Convertible Debentures
WarrantsIssuedInConnectionWithConvertibleDebentures
0 USD
tnxp Warrants Issued In Connection With Convertible Debentures
WarrantsIssuedInConnectionWithConvertibleDebentures
81337 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
24073 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
24073 USD
us-gaap Share Based Compensation
ShareBasedCompensation
833895 USD
us-gaap Share Based Compensation
ShareBasedCompensation
228532 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2385766 USD
tnxp Issuance Of Common Stock To Intellectual Property
IssuanceOfCommonStockToIntellectualProperty
0 USD
tnxp Issuance Of Common Stock To Intellectual Property
IssuanceOfCommonStockToIntellectualProperty
0 USD
tnxp Issuance Of Common Stock To Intellectual Property
IssuanceOfCommonStockToIntellectualProperty
383250 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
7908 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-178297 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-27889 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
46362 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
635401 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-208260 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1461238 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-3155 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-35195 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3111 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
289989 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
282515 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
694055 USD
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-2774 USD
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-1027 USD
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
23381 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2123058 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2907427 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12326761 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
33814 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
78535 USD
tnxp Repayments Of Restricted Cash
RepaymentsOfRestrictedCash
45 USD
tnxp Repayments Of Restricted Cash
RepaymentsOfRestrictedCash
45 USD
tnxp Repayments Of Restricted Cash
RepaymentsOfRestrictedCash
60312 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-33859 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-138847 USD
us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
0 USD
us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
0 USD
us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
480000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1020000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1891000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
150000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
150000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4387894 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6932894 USD
tnxp Proceeds From Issuance Of Capital Stock
ProceedsFromIssuanceOfCapitalStock
0 USD
tnxp Proceeds From Issuance Of Capital Stock
ProceedsFromIssuanceOfCapitalStock
0 USD
tnxp Proceeds From Issuance Of Capital Stock
ProceedsFromIssuanceOfCapitalStock
1954001 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
405750 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4237894 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12533645 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-1717353 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
1296608 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
68037 USD
CY2011Q4 us-gaap Cash
Cash
41123 USD
CY2007Q2 us-gaap Cash
Cash
0 USD
CY2012Q2 us-gaap Cash
Cash
1337731 USD
us-gaap Interest Paid
InterestPaid
3115 USD
us-gaap Interest Paid
InterestPaid
35195 USD
us-gaap Interest Paid
InterestPaid
38310 USD
tnxp Convertible Notes Exchanged For Preferred Shares
ConvertibleNotesExchangedForPreferredShares
0 USD
tnxp Convertible Notes Exchanged For Preferred Shares
ConvertibleNotesExchangedForPreferredShares
0 USD
tnxp Convertible Notes Exchanged For Preferred Shares
ConvertibleNotesExchangedForPreferredShares
200000 USD
tnxp Capital Contribution Of Accrued Interest
CapitalContributionOfAccruedInterest
0 USD
tnxp Capital Contribution Of Accrued Interest
CapitalContributionOfAccruedInterest
0 USD
tnxp Capital Contribution Of Accrued Interest
CapitalContributionOfAccruedInterest
26836 USD
tnxp Demand Notes And Accrued Interest Converted In To Capital Stock
DemandNotesAndAccruedInterestConvertedInToCapitalStock
0 USD
tnxp Demand Notes And Accrued Interest Converted In To Capital Stock
DemandNotesAndAccruedInterestConvertedInToCapitalStock
0 USD
tnxp Demand Notes And Accrued Interest Converted In To Capital Stock
DemandNotesAndAccruedInterestConvertedInToCapitalStock
549078 USD
tnxp Common Stock Issued For Deferred Financing Costs
CommonStockIssuedForDeferredFinancingCosts
0 USD
tnxp Common Stock Issued For Deferred Financing Costs
CommonStockIssuedForDeferredFinancingCosts
0 USD
tnxp Common Stock Issued For Deferred Financing Costs
CommonStockIssuedForDeferredFinancingCosts
144000 USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0 USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0 USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
820000 USD
tnxp Adjustment To Additional Paid In Capital Reclassification Of Warrants To Equity
AdjustmentToAdditionalPaidInCapitalReclassificationOfWarrantsToEquity
0 USD
tnxp Adjustment To Additional Paid In Capital Reclassification Of Warrants To Equity
AdjustmentToAdditionalPaidInCapitalReclassificationOfWarrantsToEquity
3938946 USD
tnxp Adjustment To Additional Paid In Capital Reclassification Of Warrants To Equity
AdjustmentToAdditionalPaidInCapitalReclassificationOfWarrantsToEquity
3938946 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1925000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2635000 USD
tnxp Proceeds From Security Deposit
ProceedsFromSecurityDeposit
0 USD
tnxp Proceeds From Security Deposit
ProceedsFromSecurityDeposit
0 USD
tnxp Proceeds From Security Deposit
ProceedsFromSecurityDeposit
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
200000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
200000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
306666 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
306666 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
100916 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
100916 USD
tnxp Capitalization Of Deferred Financing Cost
CapitalizationOfDeferredFinancingCost
100916 USD
tnxp Capitalization Of Deferred Financing Cost
CapitalizationOfDeferredFinancingCost
0 USD
tnxp Capitalization Of Deferred Financing Cost
CapitalizationOfDeferredFinancingCost
100916 USD
us-gaap Common Stock Conversion Basis
CommonStockConversionBasis
Pursuant to the Share Exchange, each share of Tonix Subs common stock was exchanged for 0.045 shares of Tamandares common stock and each share of Tonix Subs Series A and B preferred stock was exchanged for 0.24 shares of Tamandares common stock.
tnxp Sale Of Stock Number Of Shares Outstanding In Transaction
SaleOfStockNumberOfSharesOutstandingInTransaction
1133334 shares
tnxp Common Stock Shares Outstanding Retained
CommonStockSharesOutstandingRetained
200000 shares
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1133334 shares
us-gaap Sale Of Stock Percentage Of Ownership After Transaction
SaleOfStockPercentageOfOwnershipAfterTransaction
0.85 pure
CY2013Q2 tnxp Recognized Compensation For Vested Warrants
RecognizedCompensationForVestedWarrants
13638 USD
tnxp Recognized Compensation For Vested Warrants
RecognizedCompensationForVestedWarrants
24073 USD
CY2013Q2 tnxp Share Based Compensation Non Vested Warrants Not Yet Recognized
ShareBasedCompensationNonVestedWarrantsNotYetRecognized
27275 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Use of estimates</u></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"><font size="2">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and disclosures of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates. Significant estimates include the useful life of fixed assets and assumptions used in the fair value of stock-based compensation.</div> </div>
CY2013Q2 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
62500 USD
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
125000 USD
CY2012Q2 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
62500 USD
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
138750 USD
CY2013Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1232400 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
376500 shares
tnxp Reverse Stock Split Effective Date
ReverseStockSplitEffectiveDate
2013-05-01
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
20-for-1
CY2013Q2 tnxp Shares Outstanding Before Reverse Stock Split
SharesOutstandingBeforeReverseStockSplit
43182599 shares
us-gaap Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares
StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares
2159156 shares
us-gaap Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
41024 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
41024 USD
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
441572 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
833895 USD
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
228532 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
228532 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.0202 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9996 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0.0 USD
CY2013Q2 tnxp Number Of Share Warrants Vested
NumberOfShareWarrantsVested
1227000 shares

Files In Submission

Name View Source Status
0001144204-13-046004-index-headers.html Edgar Link pending
0001144204-13-046004-index.html Edgar Link pending
0001144204-13-046004.txt Edgar Link pending
0001144204-13-046004-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
tnxp-20130630.xml Edgar Link completed
tnxp-20130630.xsd Edgar Link pending
tnxp-20130630_cal.xml Edgar Link unprocessable
tnxp-20130630_def.xml Edgar Link unprocessable
tnxp-20130630_lab.xml Edgar Link unprocessable
tnxp-20130630_pre.xml Edgar Link unprocessable
v351868_10q.htm Edgar Link pending
v351868_ex31-01.htm Edgar Link pending
v351868_ex31-02.htm Edgar Link pending
v351868_ex32-01.htm Edgar Link pending